Komori
Other Disclosures2931Euglena Co.,Ltd.Food

Euglena Co.,Ltd. becomes the first private-sector company to join the “Yaima Jin Project,” which aims to prevent the progression of chronic kidney disease in Okinawa’s Yaeyama region

Euglena Co.,Ltd. joined the “Yaima Jin Project,” a chronic kidney disease initiative led by Okinawa Prefectural Yaeyama Hospital, becoming the first private-sector company to do so. As its first initiative, it plans to hold a CKD awareness event for working-age residents of the Yaeyama region on 6 December 2026.

Worth reading
59In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
50
people (event capacity)
Wording
Definitive
How definitive the wording is.

Announced details

Yaima Jin Project, CKD awareness event “Yaima Jin: Is Kidney Disease Common!? A Health Seminar for Working Adults Living in Yaeyama: The Kidneys”
Applicable field (uses covered by this announcement)

Prevention and slowing the progression of chronic kidney disease (CKD), health education, and improvements in diet and lifestyle

Launch date6 December 2026 (scheduled; date of the CKD awareness event)
Relationship between the counterparty and the company
Euglena Co.,Ltd.2931
Relationship with the Company

Euglena Co.,Ltd. and Okinawa Prefectural Yaeyama Hospital are participating in the project and will jointly hold a CKD awareness event. Capital and personnel relationships: Not disclosed

CounterpartyOkinawa Prefectural Yaeyama Hospital

Medical institutions in the Yaeyama region, including Ishigaki, Okinawa. Dr. Waki Toru (和氣亨) is the founder of the Yaima Jin Project. Other locations, representative, capital, and year established: Not disclosed

Location (as indicated in this announcement)

Euglena Co.,Ltd. Production Technology Research Institute (287-14 Shiraho, Ishigaki, Okinawa)

Offering price

Free of charge

The company does not address Contract Value / Impact on Business Performance.

Source (materials cited by the company)

Ministry of Health, Labour and Welfare, “CKD Pamphlet for Physicians”; Japanese Society of Nephrology, “CKD Clinical Guide 2024”; Okinawa Prefectural Yaeyama Hospital, “Yaima Jin Project”

Announced details
ItemDetails
Names of Products / Services CoveredYaima Jin Project, CKD awareness event “Yaima Jin: Is Kidney Disease Common!? A Health Seminar for Working Adults Living in Yaeyama: The Kidneys”
CounterpartyOkinawa Prefectural Yaeyama Hospital
Counterparty overviewMedical institutions in the Yaeyama region, including Ishigaki, Okinawa. Dr. Waki Toru (和氣亨) is the founder of the Yaima Jin Project. Other locations, representative, capital, and year established: Not disclosed
Relationship with the CompanyEuglena Co.,Ltd. and Okinawa Prefectural Yaeyama Hospital are participating in the project and will jointly hold a CKD awareness event. Capital and personnel relationships: Not disclosed
Offering priceFree of charge
Launch date6 December 2026 (scheduled; date of the CKD awareness event)
Applicable areaPrevention and slowing the progression of chronic kidney disease (CKD), health education, and improvements in diet and lifestyle
LocationEuglena Co.,Ltd. Production Technology Research Institute (287-14 Shiraho, Ishigaki, Okinawa)
SourceMinistry of Health, Labour and Welfare, “CKD Pamphlet for Physicians”; Japanese Society of Nephrology, “CKD Clinical Guide 2024”; Okinawa Prefectural Yaeyama Hospital, “Yaima Jin Project”
Items this document does not state (9)
Contract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To help address the health issue of chronic kidney disease in the Yaeyama region and promote local residents’ understanding of CKD and their efforts to improve their health. Euglena Co.,Ltd. also cites its ongoing involvement in the region, including its business activities and the provision of ingredients for school meals, as background to its participation.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Euglena Co.,Ltd. becomes the first private-sector company to join the “Yaima Jin Project,” which aims to prevent the progression of chronic kidney disease in Okinawa’s Yaeyama region | Euglena Co.,Ltd. (2931) timely disclosure | Komori